6493.Two
6493.TWO operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to customers in the healthcare sector.
Business. 6493.TWO operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to customers in the healthcare sector.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
6493.TWO operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to customers in the healthcare sector.
The company's capital structure shows a debt-to-equity ratio of 0.49, indicating a relatively conservative leverage position. However, the liquidity position is marked by a negative net cash position after subtracting total debt, which raises concerns about short-term financial flexibility. The price-to-book ratio of 2.36 suggests that the market values the company at a premium to its book value, but the negative return on equity of -5.96% and return on assets of -3.42% indicate poor profitability relative to its capital base.
Profitability metrics are significantly below industry norms, with a negative operating income of -21.23 million TWD and a net loss of -2.13 million TWD. The company's gross profit margin of 17.63% is also underperforming compared to the industry's median, which typically exceeds 25%. These figures suggest that the company is struggling to convert its revenue into sustainable profits, which could be a red flag for investors.
The company's revenue is not segmented by product or geographic region in the available data, making it difficult to assess the concentration of risk in specific markets or product lines. However, the negative operating cash flow of -4.10 million TWD and the free cash flow of 2.08 million TWD indicate that the company is not generating sufficient cash from operations to support its capital expenditures or debt obligations.
Looking ahead, the company's growth trajectory is uncertain, as the available data does not provide forward-looking revenue guidance or outlook for the next fiscal year. The negative operating income and net loss suggest that the company may need to implement cost-cutting measures or find new revenue streams to improve its financial performance. The capital expenditure of -6.65 million TWD indicates that the company is investing in its operations, but the negative operating cash flow raises questions about the sustainability of these investments.
The risk assessment highlights a medium liquidity risk due to the negative net cash position after subtracting total debt. The dilution risk is currently low, but the company's financial performance and cash flow issues could increase the likelihood of future dilution if it needs to raise additional capital. The risk of dilution is further compounded by the company's negative net income and the potential need for further financing to support its operations.
Recent events and filings do not provide specific details about the company's strategic initiatives or financial performance beyond the reported financials. The lack of detailed information on recent events or management discussions makes it challenging to assess the company's response to market conditions or its long-term strategy. Investors should monitor the company's financial reports and any new disclosures for insights into its future direction.
- The company is operating at a loss with a negative return on equity and return on assets, indicating poor profitability.
- The debt-to-equity ratio is relatively low, but the negative net cash position raises liquidity concerns.
- The company's financial performance is below industry norms, with a low gross profit margin and negative operating income.
- The lack of detailed segment and geographic revenue data makes it difficult to assess the concentration of risk in specific markets or product lines.
- The company's growth trajectory is uncertain, and it may need to implement cost-cutting measures or find new revenue streams to improve its financial performance.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- 6493.TWO Market data — financials · 2026-05-27